Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Accounts Payables (2020 - 2025)

Historic Accounts Payables for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $145.5 million.

  • Agilon Health's Accounts Payables fell 3339.94% to $145.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $145.5 million, marking a year-over-year decrease of 3339.94%. This contributed to the annual value of $220.3 million for FY2024, which is 797.3% down from last year.
  • As of Q3 2025, Agilon Health's Accounts Payables stood at $145.5 million, which was down 3339.94% from $171.9 million recorded in Q2 2025.
  • Agilon Health's 5-year Accounts Payables high stood at $290.6 million for Q3 2023, and its period low was $95.1 million during Q1 2021.
  • Moreover, its 5-year median value for Accounts Payables was $177.4 million (2022), whereas its average is $188.8 million.
  • As far as peak fluctuations go, Agilon Health's Accounts Payables skyrocketed by 8150.13% in 2023, and later plummeted by 3880.86% in 2025.
  • Agilon Health's Accounts Payables (Quarter) stood at $112.9 million in 2021, then surged by 57.09% to $177.4 million in 2022, then soared by 34.95% to $239.4 million in 2023, then dropped by 7.97% to $220.3 million in 2024, then plummeted by 33.96% to $145.5 million in 2025.
  • Its Accounts Payables stands at $145.5 million for Q3 2025, versus $171.9 million for Q2 2025 and $226.7 million for Q1 2025.